No extra Thanksgiving ‘meals orgy’? New weight problems medicines change how customers consider vacation meals

For many of her life, Claudia Stearns dreaded Thanksgiving. As an individual who struggled with weight problems since childhood, Stearns hated the annual turmoil of obsessing about what she ate — and the guilt of overindulging on a vacation constructed round meals.

Now, after dropping practically 100 kilos utilizing medicines together with Wegovy, a robust new anti-obesity drug, Stearns says the “meals noise” in her head has gone very, very quiet.

“Final yr, it felt so pretty to simply have the ability to get pleasure from my meal, to give attention to being with family and friends, to give attention to the enjoyment of the day,” says Stearns, 65, of Somerville, Massachusetts. “That was an entire new expertise.”

As hundreds of thousands of Individuals battling weight problems achieve entry to a brand new era of weight-loss medicine, Stearns’ expertise is changing into extra widespread — and extra noticeable on the instances of yr when cooking, consuming and a way of abundance can outline and heighten gatherings of family members and buddies. Medical specialists and customers say the medicine are shifting not solely what customers eat, but additionally the best way they give thought to meals.

For some, it means larger psychological management over their meals. Others say it saps the enjoyment from social conditions, together with historically food-centric holidays like Thanksgiving, Passover and Christmas.

“It’s one thing that actually adjustments quite a lot of issues of their life,” says Dr. Daniel Bessesen, chief of endocrinology at Denver Well being, who treats sufferers with weight problems. “They go from meals being a central focus to it’s simply not.”

UNDERMINING THE FESTIVITIES?

The brand new weight problems medicine, initially designed to deal with diabetes, embrace semaglutide, utilized in Ozempic and Wegovy, and tirzepatide, utilized in Mounjaro and not too long ago permitted as Zepbound. Now aimed toward weight reduction, too, the medicine delivered as weekly injections work far otherwise than any food plan. They mimic highly effective hormones that kick in after individuals eat to manage urge for food and the sensation of fullness communicated between the intestine and the mind. Customers can lose as a lot as 15% to 25% of their physique weight, research present.

“That’s the way it works — it reduces the rewarding points of meals,” explains Dr. Michael Schwartz, an knowledgeable in metabolism, diabetes and weight problems on the College of Washington in Seattle.

For Stearns, who began remedy in 2020, utilizing the weight-loss medicines means she will be able to take a number of bites of her favourite Thanksgiving pies — after which cease.

“I might not really feel full,” she says, “however I might really feel glad.”

But such a shift can have broader implications, each spiritual and cultural, as a result of it alters the expertise of festive and spiritual holidays which are usually constructed round interactions with meals — and plenty of it.

“I’m Italian. For us, it’s like going to church, going to a desk,” says Joe Sapone, 64, a retiree from Atlantic Highlands, New Jersey, who misplaced about 100 kilos with weight-reduction plan and Mounjaro. He not wants what he known as “the meals orgy” of a vacation, however he acknowledges it was an adjustment.

“A part of succeeding at that is disconnecting time with what you eat,” he says. “Am I nonetheless going to have enjoyable if I don’t eat that a lot?”

CHANGES IN ENJOYMENT

Many customers welcome what they are saying is bigger management over what they eat, even in the course of the emotionally charged vacation season.

“I could also be extra selective of the objects I placed on my plate,” says Tara Rothenhoefer, 48, of Trinity, Florida. She misplaced greater than 200 kilos after becoming a member of a medical trial testing Mounjaro for weight reduction in 2020. “I don’t care in regards to the bread as a lot. I nonetheless eat what I get pleasure from.”

However others on the medicine lose their appetites solely or endure unwanted effects — nausea, vomiting, diarrhea — that undermine the pleasure of any meals.

“I’ve had a handful of sufferers over time who had been actually depressing as a result of they didn’t get pleasure from meals in the identical means,” says Dr. Katherine Saunders, an weight problems knowledgeable at Weill Cornell Medication and co-founder of Intellihealth, a medical and software program firm that focuses on weight problems remedy.

However, she added, most individuals who’ve turned to weight-loss medicines have spent years battling the bodily and psychological burdens of power weight problems and are relieved to find a decreased want for meals — and grateful to shed kilos.

When individuals cease taking the medicine, their appetites return they usually regain weight, usually sooner than they misplaced it, research present. One early evaluation discovered that two-thirds of sufferers who began taking weight-loss medicine had been not utilizing them a yr later.

A part of that could be on account of excessive price and ongoing provide shortages. However the bigger query of what it means to change a primary human drive like urge for food must be thought-about as nicely, says Dr. Jens Juul Holst of the College of Copenhagen. He is likely one of the researchers who first recognized the intestine hormone GLP-1, or glucagon-like peptide 1, which ultimately led to the brand new class of weight problems medicine.

Talking at a global diabetes convention this fall, Holst provided a philosophical critique of the brand new medicines’ real-world affect.

“Why is it that you just’ve misplaced weight? That’s since you’ve misplaced your urge for food. That’s since you’ve misplaced the pleasure of consuming and the reward of getting a phenomenal meal,” Holst instructed his colleagues. “And the way lengthy are you able to stand that? That’s the actual, actual query.”

___

The Related Press Well being and Science Division receives assist from the Howard Hughes Medical Institute’s Science and Academic Media Group. The AP is solely answerable for all content material.